I was looking at the Hemopure website today, and their own clinical data does not indicate to me that this is going to be a miracle cure. In the following table, the figures for "% of patients treated with Hemopure that avoided red blood cell transfusion" interested me. Does this mean that between 41% and 73% of patients who received transfusions of Hemopure needed further transfusions of red blood cells?
| % of Patients | ||||||||||||
| No. of Total | Treated with | |||||||||||
| Patients/No. of | Hemopure that | |||||||||||
| Dosing: Grams Hemoglobin | Patients Treated | Avoided Red Blood | ||||||||||
| Type of Surgery | Development Status | (Units Hemopure) | with Hemopure | Cell Transfusion | ||||||||
Elective orthopedic surgery | Phase III trial completed in U.S., Canada, Europe and South Africa | Up to 300 grams (10 units) over 6 days before, during or after surgery | 688/350 | 59% | ||||||||
Non-cardiac elective surgery | Phase III trial completed in Europe and South Africa, the basis for filing in South Africa in July 1999 | Up to 210 grams (7 units) over 6 days before, during or after surgery | 160/83 | 43% | ||||||||
Post cardiopulmonary bypass surgery | Phase II trial completed in the U.S.; supportive trial for the South African July 1999 filing | Up to 120 grams (4 units) over 3 days post-surgery | 98/50 | 34% | ||||||||
Aortic aneurysm reconstruction surgery | Phase II trial completed in the U.S. and Europe; supportive trial for the South African July 1999 filing | Up to 150 grams (5 units) over 4 days; first dose administered during or after surgery | 72/48 | 27% | ||||||||